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Abstract 
The purpose of the present study was to examine the effects of an oral β-hydroxybutyrate (BHB) salt supplement on 
cycling performance. Using a double-blind, placebo-controlled, crossover design, 12 highly-trained cyclists (mean ± 
SD: age; 35 ± 8 y, mass; 74.5 ± 7.6 kg, VO2peak; 68.0 ± 6.7 ml.min-1kg-1) were supplemented with two 30 ml servings 
of an oral BHB salt supplement or placebo formula (PLA) prior to and during exercise. Participants cycled at a 
submaximal intensity (80% of second ventilatory threshold) for 90-min, followed by a 4-min maximal cycling 
performance test (4PT). The difference in 4PT power output between trials was not statistically significant (p > 0.05) 
and was associated with a trivial effect (ES ±90%CI = 0.19 ±0.37). Ingestion of the BHB salt supplement was 
associated with a large increase in blood BHB concentrations when compared to PLA for the 4PT (ES = 1.75 ±0.50, 
p < 0.01). The increased BHB concentration was accompanied by a moderate increase in the respiratory exchange 
ratio (RER) during the submaximal exercise phase (ES = 0.54 ±0.45, p = > 0.05) and a moderate increase during the 
4PT (ES = 0.78 ±0.57, p = 0.03). Submaximal VO2 did not differ between trials, however, VO2 was higher during the 
4PT phase in the BHB trial (ES = 0.28 ±0.32; small). In conclusion, BHB salt supplementation altered blood BHB 
concentrations, RER and VO2 values during steady state sub-maximal exercise, but did not improve 4-minute cycling 
performance. 
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Introduction 
The ability to oxidise fat and spare carbohydrate reserves 
is a key determinant of endurance exercise performance 
(Holloszy and Coyle 1984), and is an adaptation 
prevalent in highly-trained compared to recreationally-
trained athletes (Hetlelid et al. 2015). This important 
feature allows for the preservation of muscle and liver 
glycogen, thereby improving the high-intensity end-
spurt ability following prolonged endurance exercise 
(Rowlands and Hopkins 2002). This is often where 
many endurance competitions longer than 2 h in duration 
are won and lost. 
Low carbohydrate ketogenic diets increase fat oxidation 
rates and blood β-hydroxybutyrate (BHB) 
concentrations (Volek et al. 2015) and have the potential 
to enhance energy provision to working muscles for 
prolonged exercise performance (Cox and Clarke 2014). 
BHB is an efficient substrate, that generates 31% more 
energy per carbon molecule (C2) than pyruvate (243.6 
kcal/mol vs 185.7 kcal/mol, respectively) (Veech 2004). 
Moreover, elevated BHB concentrations have been 
suggested to reduce glucose and glycogen metabolism 
(Cahill Jr 1976; Kashiwaya et al. 1994; Robinson and 
Williamson 1980), in turn sparing carbohydrate stores 
during prolonged exercise, potentially aiding subsequent 
performance in sports like road cycling or triathlon 
(Lambert et al. 1994; Phinney et al. 1983). However, the 
personal discipline required to increase blood BHB 
concentrations and achieve nutritional ketosis, by 
consuming less than ~50 g of carbohydrate per day, may 
limit its application for many athletes. Moreover, the 
inherent low carbohydrate consumption levels required 
to achieve ketosis have the potential to reduce an 
athlete’s ability to perform high-intensity exercise 
(Havemann et al. 2006; Hawley and Leckey 2015). 
One strategy less considered in the literature to enhance 
blood BHB levels is the ingestion of a BHB supplement. 
Indeed, numerous synthetic BHB supplements now 
available claim the ability to rapidly induce ketosis 
(defined as > 0.5 mmol/L), but few studies have 
considered this in the context of exercise performance 
(Clarke et al. 2012a; Clarke et al. 2012b; Kesl et al. 
2016; Pinckaers et al. 2016; Veech 2014). Therefore, the 
purpose of the current study was to assess the effects of 
an oral BHB salt supplement in comparison to a placebo 
supplement on exercise metabolism over 90 minutes’ 
submaximal cycling, and subsequent all-out 4-minute 
exercise performance in highly-trained cyclists.  
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Materials and methods 
Participants 
Twelve highly-trained male cyclists (mean ± SD: age, 
35 ± 8 y; mass, 74.5 ± 7.6 kg; VO2peak, 68.0 ± 6.7 ml.min-
1.kg-1) volunteered to participate in the current study. All 
testing took place during the competitive phase of the 
New Zealand cycling season where participants raced at 
either professional, A or B-grade level. Following an 
explanation of all procedures, risks and benefits, each 
participant gave their written informed consent to 
partake in the study, which was approved by the 
Institution’s Human Research Ethics Committee. The 
current study also adheres to the international ethical 
standards required by the Journal (Harriss and Atkinson 
2011). 
 
Participants 
Twelve highly-trained male cyclists (mean ± SD: age, 
35 ± 8 y; mass, 74.5 ± 7.6 kg; VO2peak, 68.0 ± 6.7 
ml.min-1.kg-1) volunteered to participate in the current 
study. All testing took place during the competitive 
phase of the New Zealand cycling season where 
participants raced at either professional, A or B-grade 
level. Following an explanation of all procedures, risks 
and benefits, each participant gave their written 
informed consent to partake in the study, which was 
approved by the Institution’s Human Research Ethics 
Committee. The current study also adheres to the 
international ethical standards required by the Journal 
(Harriss and Atkinson 2011). 
 
Experimental design 
The study implemented a double-blind, placebo-
controlled, randomised, crossover design that required 
participants to visit the laboratory on three separate 
occasions. Prior to taking part in the study, participants 
were required to refrain from taking any nutritional 
supplements in the 4 weeks preceding the study, as well 
as during the course of the experiment. At the start of the 
study, participants all self-reported to be on mixed CHO 
diets (neither low or high in CHO). Participants were 
asked to document their food intake via a 48-h food diary 
and were instructed not to eat within the 2.5-h period 
before the test.  Diet was replicated in the 48-h period 
prior to the subsequent experimental testing session. In 
the 24-h preceding each trial, participants were asked to 
refrain from strenuous activity and abstain from 
consuming caffeine on the day of the test. On the first 
visit to the laboratory, participants performed an 
incremental VO2peak test on their own bicycle attached 
to a Cyclus II ergometer (RBM elektronik-automation 
GmbH, Leipzig, Germany), where power output 
commenced at 150 W, and increased by 40 W every 4 
min until volitional exhaustion. VO2peak was 
determined as the highest 30 sec average of samples 
attained by participants during the incremental step test. 
Immediately following the progressive exercise test, a 
familiarisation trial that simulated the experimental 
trials (described below) was performed, however, to 
reduce the demands of the test, the submaximal exercise 
bout was reduced to 20 minutes.  
 
Exercise testing 
The experimental trials, shown in Figure 1, were 
conducted on a Wattbike cycle ergometer (Wattbike Ltd, 
Nottingham, UK), set-up to replicate each participant’s 
own bicycle.  The 4-minute maximal performance test 
(4PT) on a Wattbike has been shown to be reliable for 
testing highly-trained athletes in a laboratory setting, 
with a test-retest coefficient of variation of ~2.7% 
(Driller et al. 2014). For each experimental trial, 
participants cycled for 90 min at 80% of their second 
ventilatory threshold (VT2, as determined during the 
VO2peak test); (referred hereafter as submaximal 
exercise), prior to a paced 4PT, separated by 2 min 
passive rest allowing athletes to remove the mask if 
needed to communicate with researchers or drink water. 
VT2 was calculated using gas exchange measures and 
 
 
Figure 1. Experimental trial - timeline of events. Abbreviations: BK= blood β-hydroxybutyrate concentration; BG= blood glucose 
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identified as the intensity where VE/VCO2 began to rise 
(Davis 1985). During the 90 min submaximal cycling 
phase, participants were asked their rating of perceived 
exertion (RPE) every 15 min (Borg 1982). 
Oral β-hydroxybutyrate (BHB) salt supplementation  
Twenty minutes prior to the trial, participants ingested 
either a supplement containing 11.7g of BHB salt (BHB: 
30 ml of Ketoforce; Prototype Nutrition, IL, USA) or a 
taste-matched placebo (PLA: 3g NaCL), diluted with 
100 ml of sugar-free lemonade. A second identical dose 
of the BHB salt supplement or PLA was ingested at the 
halfway point (45 min) during the 90 min submaximal 
cycling phase. The reason for re-ingestion was based on 
our own unpublished observations, showing that BHB 
levels peaked 45 min after ingesting the supplement. The 
30 ml dose of the supplement was based on the 
manufacturers instructions.  
 
 
 
Table 1. Mean values for the performance and blood measures in the Placebo (PLA) and β-hydroxybutyrate (BHB) trials. 
Difference between trials with 90% confidence intervals (90%CI) and effect sizes (ES) are also displayed. # significant difference 
between trials (p < 0.05). 
 
 
PLA 
Mean ± SD 
BHB 
Mean ± SD 
BHB–PLA  ±90%CI 
Effect size ±90%CI 
4PT Mean Power (W) 355 ± 46 364 ± 58 9 ±18 
ES = 0.19 ±0.37 
Trivial 
4PT BHB levelsa 
(mmol/L) 
0.3 ± 0.3 0.6 ± 0.2 0.3 ±0.1# 
ES = 1.75 ±0.50 
Large 
Submaximal BHB levelsb 
(mmol/L) 
0.3 ± 0.3 0.6 ± 0.3 0.4 ±0.2# 
ES = 1.23 ±0.71 
Large 
4PT GLU levelsa 
(mmol/L) 
4.6 ± 1.2 4.6 ± 0.9 0.1 ±0.5 
ES = 0.05 ±0.55 
Unclear 
Submaximal GLU levelsb 
(mmol/L) 
4.3 ± 0.8 4.1 ± 0.7 -0.2 ±0.3 
ES = -0.24 ±0.43 
Small 
4PT lactate levelsa 
(mmol/L) 
7.6 ± 1.7 8.8 ± 3.2 1.1 ±2.1 
ES = 0.60 ±1.11 
Unclear 
Submaximal lactate levelsb 
(mmol/L) 
1.6 ± 0.5 1.8 ± 0.7 0.1 ±0.4 
ES = 0.28 ±0.81 
Unclear 
a = taken immediately post 4PT. b = taken immediately post submaximal exercise bout (90min). Abbreviations: 4PT= 4 min 
performance test; BHB= β-hydroxybutyrate; GLU= glucose. 
 
 
Table 2. Mean values for the measured metabolic variables in the placebo (PLA) and β-hydroxybutyrate salt supplement (BHB) 
trials. Difference between trials with 90% confidence intervals (90%CI) and effect sizes (ES) are also displayed. # significant 
difference between trials (p < 0.05). 
 
 PLA 
Mean ± SD 
BHB 
Mean ± SD 
BHB – PLA ±90% CI 
Effect size ±90% CI 
4PT RER 0.96 ± 0.05 1.01 ± 0.07 0.04 ±0.03# 
ES = 0.78 ±0.57 
Moderate 
Submaximal RERa 0.85 ± 0.03 0.87 ± 0.05 0.02 ±0.02 
ES = 0.54 ±0.45 
Moderate 
4PT VO2 
(L.min-1) 
3.88 ± 0.35 3.99 ± 0.49 0.11 ±0.13 
ES = 0.28 ±0.35 
Small 
Submaximal VO2b 
(L.min-1) 
3.26 ± 0.33 3.19 ± 0.35 -0.07 ±0.15 
ES = -0.20 ±0.41 
Unclear 
a= average taken from the 85-90 min gas sample. b= average across all gas samples during the sub maximal bout. 
Abbreviations: 4PT= 4 min performance test; BHB= β-hydroxybutyrate; PLA= placebo; RER= respiratory exchange ratio. 
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Blood sampling 
Finger-tip blood samples were taken to assess blood 
glucose and blood BHB levels using a commercially 
available Freestyle Optium blood glucose and blood 
ketone monitoring system (Abbot Diabetes Care, Oxon, 
UK), as used previously (Guimont et al. 2015). Blood 
lactate was measured using a Lactate Pro 2 Analyser 
(Arkray KDK, Shiga, Japan) alongside blood glucose 
and BHB measures at the end of the 90 min submaximal 
cycling test and 4PT.   
 
Statistical analysis 
Data are reported as means ± SD unless otherwise stated. 
An excel spreadsheet was used to identify differences 
between trials for each physiological and performance 
response (Hopkins 
2006). To make 
inferences about the 
likely range of the true 
effect, the uncertainty in 
the effect was expressed 
as ±90% confidence 
interval (CI). 
Standardised differences 
in the mean of each 
measure were used to 
assess magnitudes of 
effects and were 
calculated using Cohen’s 
d and interpreted using 
thresholds of 0.2, 0.6, 1.2 
and 2.0 for small, 
moderate, large and very 
large, respectively 
(Hopkins 1997). An 
effect size (ES) of <0.2 
considered trivial and the 
effect was deemed 
unclear if its 90% 
confidence interval 
overlapped the 
thresholds for small 
positive and negative 
effects. The thresholds 
used to determine small 
positive and negative 
effects were an effect 
size of 0.2, or, where 
known, the value of the 
smallest worthwhile 
change (e.g. 0.3 of the 
CV = 0.81% for mean 
power) (Hopkins 2006; 
Hopkins and Batterham 
2006). Normality of the 
data for all measures was 
verified visually with 
histograms and also by 
the Shapiro-Wilk test. A 
student’s paired t-test 
was used to compare 
BHB and PLA for all 
measured variables in the Statistical Package for Social 
Science (V. 24.0, SPSS Inc., Chicago, IL), with an alpha 
level set at p < 0.05.  
 
Results 
There were no significant differences (p = 0.38), and a 
trivial effect (ES = 0.19 ±0.37) between BHB and PLA 
trials for power output during the 4PT (Table 1).   
The BHB salt supplement trial revealed a significant (p 
< 0.01) increase in blood BHB levels during the 4PT, 
and also during submaximal exercise (Table 1, Figure 
2). These differences between trials were associated with 
large effect sizes (Table 1). The difference in blood 
lactate concentrations after both the submaximal and 
 
Figure 2. Key physiological measures during submaximal exercise for the placebo (PLA) and β-
hydroxybutyrate salt supplement (BHB) trials. Error bars represent 90% confidence intervals. *=small 
effect, **=moderate effect. 
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4PT exercise phases were unclear between trials (ES = 
0.28 ±0.81 and 0.60 ±1.11, repectively). Differences in 
average blood glucose during submaximal exercise were 
small between the BHB trial and placebo trials (ES = -
0.24 ±0.43, p = 0.33)., while blood glucose following the 
4PT was unclear between trials (ES = 0.05 ±0.55). 
There was a moderate increase in mean RER (ES = 0.54 
±0.45, p = 0.06) for the BHB trial compared with the 
PLA trial during the 90 min submaximal exercise phase 
(Table 2; Figure 2). Similarly, there were moderate 
increases in mean RER during the 4PT (ES =0.78 ±0.57, 
p = 0.03) in the BHB compared to PLA trial. The 
average difference in VO2 between trials during the 
submaximal phase was unclear (ES = -0.20 ±0.41). 
Conversely, there were small (ES = 0.28 ±0.35) 
increases in VO2 observed in the BHB trial compared to 
the PLA trial during the 4PT. 
Ratings of perceived exertion were not significantly 
different between trials (ES = -0.12 ±0.33; unclear). 
 
Discussion 
To our knowledge, this is the first study to examine the 
effects of an oral β-hydroxybutyrate (BHB) salt 
supplement on exercise performance in highly-trained 
cyclists. The main findings were that acute oral BHB salt 
supplementation resulted in large increases in blood 
BHB concentrations as well as a moderate increase in 
the RER, but failed to improve 4-minute all-out cycling 
performance following 90-minutes of submaximal 
exercise.  
Even though analysis revealed a large increase in blood 
BHB levels following BHB salt supplementation both 
during submaximal and maximal exercise, it is possible 
that the increased BHB concentrations achieved were 
not great enough to elicit a benefit in performance. BHB 
values above 2mmol/L have been reported in humans 
without side effects following ingestion of a ketone ester 
supplement (Clarke et al. 2012b). However, acute BHB 
supplementation has the potential to cause 
gastrointestinal distress, which may counteract any 
added benefits associated with higher doses. Indeed, it 
may be possible that chronic ingestion of BHB with a 
dose that is tolerable may have a greater impact on 
exercise performance. Average blood BHB 
concentrations achieved in the current study (0.63 
mmol/L) peaked far below the levels required for 
therapeutic ketosis (≥2 mmol/L) (Hashim and VanItallie 
2014). Alternatively, research by Johnson and Walton 
(1972) demonstrated that trained athletes may have an 
increased tolerance to ketosis during exercise and that 
low blood ketone concentration values may in fact 
represent the utilisation of BHB as a fuel.  
The increased RER levels, which coincided with the 
increased BHB concentrations during submaximal 
exercise, was in contrast to previous research resulting 
in similar blood BHB levels after adaptation to a 
ketogenic diet (Lambert et al. 2001; Phinney et al. 1980; 
Zajac et al. 2014). Phinney et al. (1980) demonstrated 
lower RER values during exercise following a ketogenic 
diet (RER = < 0.70) for 6 weeks compared to a pre-diet 
control condition (RER = 0.76). It has been postulated 
that BHB supplementation may act as a signal, limiting 
glucose and glycogen metabolism (Cahill Jr 1976). 
Therefore, BHB supplementation may spare glycogen 
for subsequent high-intensity exercise (Robinson and 
Williamson 1980). The higher RER and VO2 in the 
BHB trial during the 4PT supports this possibility, 
however due to the fact that muscle glycolysis rates were 
not measured, these findings remain inconclusive.   
A limitation of the current study was the exercise 
protocol used. The short performance test may have 
limited our ability to test the capacity of the ketone 
supplement’s glycogen storing capabilities; however, 
we chose to employ a 4-minute performance test to 
reflect the characteristics of a typical road race that has 
a period of sub-maximal cycling, followed by a high-
intensity surge in the last kilometers towards the finish 
line. Indeed, as evidenced by the RER levels in the 
current study, 90 minutes at VT2 was likely to lack the 
intensity and/or duration required to sufficiently reduce 
glycogen stores and have any 
effect on the 4PT.  This should be considered in future 
research, along with tighter control on the dietary history 
of participants leading into the study. 
  
Practical Applications 
The present study has shown that BHB salt 
supplementation increased blood BHB 
concentrations but did not significantly improve 4-
minute maximal cycling performance in highly-
trained cyclists. While the current study failed to 
show any benefit, further research is required, 
implementing higher dosing regimens of BHB 
supplementation, perhaps utilizing a chronic dosing 
protocol or ketone esters. Furthermore, different 
exercise protocols designed to sufficiently reduce 
carbohydrate stores should be implemented in 
future studies before disregarding BHB 
supplementation as a possible supplement to 
improve performance. 
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